Caribou Biosciences (CRBU) Research & Development (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Research & Development data on file, last reported at $20.6 million in Q1 2026.

• Quarterly Research & Development fell 41.99% year-over-year to $20.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.5 million (down 28.34% YoY) and the FY2025 annual result came in at $109.4 million, down 15.92% from the prior year.
• Research & Development slipped to $20.6 million in Q1 2026 per CRBU's latest filing, from $23.8 million in the prior quarter.
• Across five years, Research & Development topped out at $35.5 million in Q1 2025 and bottomed at $13.9 million in Q1 2022.
• The 5-year median for Research & Development is $26.5 million (2023), against an average of $26.7 million.
• The widest annual swing landed in 2023, when Research & Development soared 84.64%; it then slumped 41.99% in 2026.
• Tracing CRBU's Research & Development over 5 years: stood at $25.7 million in 2022, then climbed by 21.54% to $31.3 million in 2023, then dropped by 2.61% to $30.5 million in 2024, then retreated by 21.83% to $23.8 million in 2025, then declined by 13.45% to $20.6 million in 2026.
• Per Business Quant, the three latest CRBU Research & Development figures stand at $20.6 million (Q1 2026), $23.8 million (Q4 2025), and $22.4 million (Q3 2025).

Peer Comparison